Monday's ETF Movers: FBT, XBI
Biotech ETF Performance: The SPDR S&P Biotech ETF is down approximately 4.4% in afternoon trading, with significant declines in individual stocks such as Vaxcyte (down 50.5%) and Capricor Therapeutics (down 18.3%).
Market Commentary: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Analyst Views on PCVX
About PCVX
About the author


U.S. Stock Market Trends: U.S. stock futures are down, with the Dow futures dropping approximately 200 points, reflecting a bearish sentiment in the market.
Crypto-Linked Stocks Performance: Shares of crypto-related companies, including CleanSpark Inc, fell significantly in pre-market trading as Bitcoin's value dropped below $86,000.
Notable Stock Declines: Several stocks experienced sharp declines in pre-market trading, including Columbus Circle Capital I Corp (-19.2%) and Vaxcyte Inc (-11.6%).
General Market Sentiment: The overall market sentiment appears negative, with multiple stocks in the tech and crypto sectors showing substantial losses following the decline in Bitcoin prices.

Vaxcyte (PCVX) Analyst Ratings: Analysts maintain a Strong Buy consensus for Vaxcyte, with a price target suggesting a 105.7% upside; Mizuho Securities recently reaffirmed a Buy rating with a $149.43 target.
Envista Holdings (NVST) and Innovent Biologics (IVBXF): Envista received a Sell rating from Mizuho with a target of $18.00, while Innovent was rated Buy by Bernstein with a target of HK$47.00, indicating a Strong Buy consensus overall.
U.S. Stock Market Performance: U.S. stock indexes fell on Friday, with the NASDAQ down 1.49%, S&P 500 down 1.11%, and Dow down 0.77%. Small-cap stocks also declined, while IonQ Inc. experienced the largest drop among major companies.
Global Market Trends: Asian and European stock markets saw gains, with Japan's NIKKEI 225 up 1.80% and the STOXX Europe 600 Index rising 0.67%. Meanwhile, commodities like Brent crude oil and gold futures decreased slightly.
Vaxcyte Inc Trading Update: Vaxcyte Inc (PCVX) shares have entered oversold territory with an RSI of 27.1, indicating potential exhaustion of recent selling pressure, as the stock trades around $80.30, significantly below its 52-week high of $121.055.
Market Comparison: In contrast, the S&P 500 ETF (SPY) has a higher RSI of 45.6, suggesting that PCVX may present a buying opportunity for bullish investors looking to capitalize on the current market conditions.
IWM Share Price Analysis: The IWM ETF has a 52-week low of $161.67 and a high of $228.63, with the latest trade at $226.26, indicating a strong position near its high point.
ETFs Trading Dynamics: ETFs function like stocks but involve trading units that can be created or destroyed based on investor demand, affecting the underlying holdings significantly during notable inflows or outflows.
Market Performance: Major US stock indices, including the S&P 500 and Nasdaq 100, experienced significant declines due to weak economic reports and concerns over China's economy, with chip stocks leading the downturn.
Interest Rates and Economic Outlook: The financial markets are closely monitoring upcoming US economic data for insights into the economy's health, with expectations of potential interest rate cuts by the Federal Reserve following disappointing manufacturing and construction spending figures.









